References

  1. American Diabetes Association. Standards of medical care in diabetes—2007. Diabetes Care. 2007;30(suppl):S4-S41. Available at: http://care.diabetesjournals.org/cgi/content/full/30/suppl_1/S4. Accessed February 12, 2007.
  2. Nathan DM, Buse JB, Davidson MB, et al. Management of hypoglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care. 2006;29:1963-1972.
  3. Depomed®, Inc. Patent Summary. US patent 6,488,962.
  4. Foster RH, Keam SJ. Metformin extended release. Am J Drug Deliv. 2006;4:177-186.
  5. Glumetza [package insert]. Menlo Park, Calif: Depomed, Inc; 2007.
  6. Schwartz S, Fonseca V, Berner B, Cramer M, Chiang YK, Lewin A. Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes. Diabetes Care. 2006;29:759-764.
  7. Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL. Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med. 1997;103:491-497.
  8. Blonde L, Dailey GE, Jabbour SA, Reasner CA, Mills DJ. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study. Curr Med Res Opin. 2004;20:565-572.
  9. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
  10. Resnick HE, Foster GL, Bardsley J, Ratner RE. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002. Diabetes Care. 2006;29:531-537.
  11. Nathan DM, Buse JB, Davidson MB, et al. Management of hypoglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: Update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2008;31:173-175.
shadow